Latest Cutter Capital Management, LP Stock Portfolio

Cutter Capital Management, LP Performance:
2025 Q1: -0.08%YTD: -0.08%2024: -1.96%

Performance for 2025 Q1 is -0.08%, and YTD is -0.08%, and 2024 is -1.96%.

About Cutter Capital Management, LP and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Cutter Capital Management, LP reported an equity portfolio of $229.6 Millions as of 31 Mar, 2025.

The top stock holdings of Cutter Capital Management, LP are BMY, AMGN, BIIB. The fund has invested 7.8% of it's portfolio in BRISTOL-MYERS SQUIBB CO and 6.8% of portfolio in AMGEN INC.

The fund managers got completely rid off REGENERON PHARMACEUTICALS (REGN), JOHNSON & JOHNSON (JNJ) and ABBVIE INC (ABBV) stocks. They significantly reduced their stock positions in ROYALTY PHARMA PLC (RPRX), NEWAMSTERDAM PHARMA COMPANY (NAMS) and BRIDGEBIO PHARMA INC (BBIO). Cutter Capital Management, LP opened new stock positions in BRISTOL-MYERS SQUIBB CO (BMY), BIOGEN INC (BIIB) and ELI LILLY & CO (LLY). The fund showed a lot of confidence in some stocks as they added substantially to CENTESSA PHARMACEUTICALS PLC (CNTA), TARSUS PHARMACEUTICALS INC (TARS) and PERRIGO CO PLC (PRGO).

Cutter Capital Management, LP Annual Return Estimates Vs S&P 500

Our best estimate is that Cutter Capital Management, LP made a return of -0.08% in the last quarter. In trailing 12 months, it's portfolio return was -0.84%.
20242025−100102030Performance (%)PerformanceS&P 500

New Buys

Ticker$ Bought
bristol-myers squibb co17,992,000
biogen inc15,531,300
eli lilly & co14,866,400
roivant sciences ltd13,117,000
verona pharma plc10,158,400
madrigal pharmaceuticals inc7,949,520
summit therapeutics inc7,716,000
halozyme therapeutics inc7,657,200

New stocks bought by Cutter Capital Management, LP

Additions to existing portfolio by Cutter Capital Management, LP

Reductions

Ticker% Reduced
royalty pharma plc-53.34
newamsterdam pharma company-34.41
bridgebio pharma inc-30.28
agios pharmaceuticals inc-21.97
insmed inc-11.62
ultragenyx pharmaceutical in-6.76

Cutter Capital Management, LP reduced stake in above stock

Sold off

Ticker$ Sold
viridian therapeutics inc-12,051,700
akero therapeutics inc-6,398,600
vera therapeutics inc-8,994,910
moderna inc-8,212,050
neumora therapeutics inc.-1,590,000
johnson & johnson-20,474,100
sarepta therapeutics inc-15,108,300
janux therapeutics inc-6,424,800

Cutter Capital Management, LP got rid off the above stocks

Sector Distribution

Cutter Capital Management, LP has about 100% of it's holdings in Healthcare sector.

100%
Sector%
Healthcare100

Market Cap. Distribution

Cutter Capital Management, LP has about 44.3% of it's portfolio invested in the large-cap and mega-cap stocks.

41%38%13%
Category%
MID-CAP40.7
LARGE-CAP37.8
SMALL-CAP13.1
MEGA-CAP6.5
UNALLOCATED2

Stocks belong to which Index?

About 63.3% of the stocks held by Cutter Capital Management, LP either belong to S&P 500 or RUSSELL 2000 index.

37%35%28%
Index%
Others36.8
RUSSELL 200035.4
S&P 50027.9
Top 5 Winners (%)%
BBIO
bridgebio pharma inc
26.0 %
RPRX
royalty pharma plc
23.3 %
AMGN
amgen inc
15.1 %
INSM
insmed inc
10.8 %
PRGO
perrigo co plc
9.7 %
Top 5 Winners ($)$
RPRX
royalty pharma plc
4.5 M
BBIO
bridgebio pharma inc
4.0 M
AMGN
amgen inc
2.0 M
INSM
insmed inc
1.6 M
PRGO
perrigo co plc
1.2 M
Top 5 Losers (%)%
RCUS
arcus biosciences inc
-29.1 %
TEVA
teva pharmaceutical inds ltd
-25.1 %
NAMS
newamsterdam pharma company
-17.9 %
RARE
ultragenyx pharmaceutical in
-13.0 %
CNTA
centessa pharmaceuticals plc
-12.3 %
Top 5 Losers ($)$
TEVA
teva pharmaceutical inds ltd
-4.1 M
RCUS
arcus biosciences inc
-2.4 M
RARE
ultragenyx pharmaceutical in
-2.2 M
NAMS
newamsterdam pharma company
-1.6 M
CYTK
cytokinetics inc
-1.0 M

Cutter Capital Management, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

BMYAMGNBIIBLLYINSMRAREBBIOPRGOROIVTEVARPRXTARSVRNAMDGLSMMTHALOCYTKAGIOCNTARCUSNAMS

Current Stock Holdings of Cutter Capital Management, LP

Cutter Capital Management, LP has 21 stocks in it's portfolio. About 62.8% of the portfolio is in top 10 stocks. TEVA proved to be the most loss making stock for the portfolio. RPRX was the most profitable stock for Cutter Capital Management, LP last quarter.

Last Reported on: 15 May, 2025
TickerNamesorted descending% PortfolioShares Held$ ValueType% ChangeOptions

Historical Trend of BRISTOL-MYERS SQUIBB CO Position Held By Cutter Capital Management, LP

What % of Portfolio is BMY?:

Number of BMY shares held:

Change in No. of Shares Held: